Evoke Wealth, LLC Arvinas, Inc. Transaction History

Evoke Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$20.19 - $84.93 $1,413 - $5,945	-70 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$29.88 - $56.74 $179 - $340	-6 Reduced 7.89%	70 $2,000
Q1 2020 May 07, 2020	BUY	$33.0 - $54.5 $198 - $327	6 Added 8.57%	76 $3.06 Million
Q3 2019 Nov 12, 2019	BUY	$21.55 - $27.61 $1,508 - $1,932	70 New	70 $1.51 Million

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.38B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.